Hydroxyurea reduces infections in children with sickle cell anemia in Uganda

被引：3

作者：

Namazzi, Ruth ^{[1
,2
]}

Bond, Caitlin ^{[3
]}

Conroy, Andrea L. ^{[3
]}

Datta, Dibyadyuti ^{[3
]}

Tagoola, Abner ^{[4
]}

Goings, Michael J. ^{[3
]}

Jang, Jeong Hoon ^{[5
,6
]}

Ware, Russell E. ^{[7
]}

Opoka, Robert ^{[2
]}

John, Chandy C. ^{[3
]}

机构：

[1] Makerere Univ, Coll Hlth Sci, Dept Pediat & Child Hlth, Kampala, Uganda

[2] Global Hlth Uganda, Kampala, Uganda

[3] Indiana Univ Sch Med, Ryan White Ctr Pediat Infect Dis & Global Hlth, Dept Pediat, 705 Riley Hosp Dr,RI5900, Indianapolis, IN 46202 USA

[4] Jinja Reg Referral Hosp, Dept Pediat, Jinja, Uganda

[5] Yonsei Univ, Underwood Int Coll, Seoul, South Korea

[6] Yonsei Univ, Dept Appl Stat, Seoul, South Korea

[7] Cincinnati Childrens Hosp, Med Ctr, Dept Pediat, Div Hematol, Cincinnati, OH USA

来源：

BLOOD | 2024年 / 143卷 / 14期

关键词：

TOXOPLASMA-GONDII; MALARIA; DISEASE; TRIAL;

D O I：

10.1182/blood.2023021575

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

After starting hydroxyurea treatment, Ugandan children with sickle cell anemia had 60% fewer severe or invasive infections, including malaria, bacteremia, respiratory tract infections, and gastroenteritis, than before starting hydroxyurea treatment (incidence rate ratio, 0.40 [95% confidence interval, 0.29-0.54]; P < .001). © 2024 American Society of Hematology

引用

页码：1425 / 1428

页数：4

共 50 条

[1] Hydroxyurea Treatment Reduces Infection Rates in African Children with Sickle Cell Anemia
Williams, Thomas N.
Latham, Teresa S.
Tomlinson, George A.
Olupot-Olupot, Peter
Santos, Brigida
Tshilolo, Leon
Lane, Adam C.
Aygun, Banu
Stuber, Susan E.
Smart, Luke R.
Ware, Russell E.
BLOOD, 2024, 144 : 545 - 546
[2] Hydroxyurea Reduces the Transfusion Burden in Children with Sickle Cell Anemia: The Reach Experience
Power-Hays, Alexandra
Tomlinson, George A.
Tshilolo, Leon
Santos, Brigida
Williams, Thomas N.
Olupot-Olupot, Peter
McGann, Patrick T.
Aygun, Banu
Lane, Adam
Stuber, Susan E.
Latham, Teresa
Ware, Russell E.
BLOOD, 2021, 138
[3] Hydroxyurea Reduces the Hypercoagulable State In Sickle Cell Anemia
Colella, Marina P.
Machado-Neto, Joao
Quaino, Susan K. P.
Conran, Nicola
Annichino-Bizzacchi, Joyce M.
Costa, Fernando Ferreira
Saad, Sara Olalla
de Paula, Erich V.
Traina, Fabiola
BLOOD, 2011, 118 (21) : 492 - 492
[4] Hydroxyurea pharmacokinetics in children with sickle cell anemia
Harrod, Virginia L.
Sparreboom, Alex
Nicole, Mortier
Susan, Strawn
Howard, Thad
Ware, Russell E.
PEDIATRIC BLOOD & CANCER, 2007, 48 (06) : 613 - 613
[5] Optimizing Hydroxyurea Dosing in Sickle Cell Anemia: The Uganda MTD Study
John, Chandy C.
Opoka, Robert
Latham, Teresa
Hume, Heather
Nakafeero, Maria
Kasirye, Phillip
Ndugwa, Christopher
Lane, Adam
Ware, Russell E.
BLOOD, 2019, 134
[6] Hydroxyurea Initiation Among Children With Sickle Cell Anemia
Reeves, Sarah L.
Jary, Hannah K.
Gondhi, Jennifer P.
Raphael, Jean L.
Lisabeth, Lynda D.
Dombkowski, Kevin J.
CLINICAL PEDIATRICS, 2019, 58 (13) : 1394 - 1400
[7] Predicting Hydroxyurea Responses in Children with Sickle Cell Anemia
Ware, Russell E.
Mortier, Nicole A.
Smeltzer, Matthew P.
Howard, Thad A.
Kimble, Amy C.
Despotovic, Jenny M.
Wu, Song
Aygun, Banu
Flanagan, Jonathan Michael
Sparreboom, Alex
BLOOD, 2011, 118 (21) : 933 - 934
[8] Hydroxyurea use among children with sickle cell anemia
Reeves, Sarah L.
Jary, Hannah K.
Gondhi, Jennifer P.
Raphael, Jean L.
Lisabeth, Lynda D.
Donnbkowski, Kevin J.
PEDIATRIC BLOOD & CANCER, 2019, 66 (06)
[9] Adherence to Hydroxyurea Therapy in Children with Sickle Cell Anemia
Thornburg, Courtney D.
Calatroni, Agustin
Telen, Marilyn
Kemper, Alex R.
JOURNAL OF PEDIATRICS, 2010, 156 (03): : 415 - 419
[10] Neurocognitive Improvement with Hydroxyurea Therapy in Children with Sickle Cell Anemia in Uganda: Interim Analysis at Month 18
Naggayi, Shubaya Kasule
Kalibala, Dennis
Opoka, Robert
Rosano, Caterina
Munube, Deogratias
Kasirye, Phillip
Mupere, Ezekiel
Mboizi, Vincent
Ssenkusu, John
Green, Nancy S.
Idro, Richard
Bangirana, Paul
BLOOD, 2023, 142

← 1 2 3 4 5 →